Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 575 of 923 entries
View as:
Phase: N/A
Priority: Normal
Start: 01/03/18
End: 11/30/18
Due: 11/30/19
Phase: N/A
Priority: Normal
Start: 01/31/10
End: 01/31/16
Due: 01/31/17
Phase: N/A
Priority: Normal
Start: 03/28/23
End: 10/31/23
Due: 10/31/24
Phase: N/A
Priority: Normal
Start: 02/28/05
End: 02/29/08
Due: 02/28/09
Phase: N/A
Priority: Normal
Start: 11/18/22
End: 12/31/27
Due: 12/31/28
Phase: N/A
Priority: Normal
Start: 03/31/11
End: 03/31/12
Due: 03/31/13
Phase: N/A
Priority: Normal
Start: 03/30/24
End: 12/30/24
Due: 12/30/25
Phase: N/A
Priority: Normal
Start: 01/31/13
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 04/30/10
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 10/31/09
End: 12/31/18
Due: 12/31/19
Phase: N/A
Priority: Normal
Start: 04/11/13
End: 11/10/16
Due: 11/10/17
Phase: N/A
Priority: Normal
Start: 01/31/07
End: 03/31/10
Due: 03/31/11
Phase: N/A
Priority: Normal
Start: 12/31/24
End: 06/30/29
Due: 06/30/30
Phase: N/A
Priority: Normal
Start: 02/28/10
End: 10/31/11
Due: 10/31/12
Phase: N/A
Priority: Normal
Start: 10/25/19
End: 12/31/19
Due: 12/31/20
Phase: N/A
Priority: Normal
Start: 02/28/03
End: 12/31/18
Due: 12/31/19
Phase: N/A
Priority: Normal
Start: 09/30/11
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 09/30/09
End: 09/30/11
Due: 09/30/12
Phase: N/A
Priority: Normal
Start: 03/18/24
End: 12/31/27
Due: 12/31/28
Phase: N/A
Priority: Normal
Start: 10/31/22
End: 12/31/24
Due: 12/31/25
Phase: N/A
Priority: Normal
Start: 11/30/14
End: 12/31/16
Due: 12/31/17
Phase: N/A
Priority: Normal
Start: 05/31/16
End: 04/30/17
Due: 04/30/18
Phase: N/A
Priority: Normal
Start: 12/26/17
End: 05/17/21
Due: 05/17/22
Phase: N/A
Priority: Normal
Start: 06/30/16
End: 03/20/18
Due: 03/20/19
Neoadjuvant FOLFOX6 + Cetuximab in Patients With Colorectal Cancer and Unresectable Liver Metastasis
Phase: N/A
Priority: Normal
Start: 06/30/08
End: 06/30/12
Due: 06/30/13